%PDF-1.4
%
1 0 obj
<<
/MarkInfo
<<
/Marked true
>>
/Metadata 3 0 R
/Outlines 4 0 R
/PageLayout/OneColumn
/Pages 5 0 R
/StructTreeRoot 6 0 R
/Type/Catalog
>>
endobj
2 0 obj
<<
/Author(CHMP)
/Company(Translation Centre)
/CreationDate(D:20130723170847+01'00')
/Creator(Acrobat PDFMaker 11 for Word)
/DM_Category(EPAR)
/DM_Creation_Date(16/07/2013 15:14:29)
/DM_Creator_Name(Flaunoe Lise)
/DM_DocRefId(EMA/436309/2013)
/DM_Language(en_GB)
/DM_Modifer_Name(Flaunoe Lise)
/DM_Modified_Date(16/07/2013 15:14:29)
/DM_Modifier_Name(Flaunoe Lise)
/DM_Modify_Date(16/07/2013 15:14:29)
/DM_Name(H-406-Summary-en)
/DM_Path(/01. Evaluation of Medicine/H-C/G-I/Glivec-000406/05 Post Authorisation/EPAR/Rev 20 \(II-80 awaiting CD\)/Summary)
/DM_Type(emea_document)
/DM_Version(CURRENT,1.0)
/DM_emea_doc_ref_id(EMA/436309/2013)
/Keywords(Glivec, INN: imatinib)
/ModDate(D:20180702151251+08'00')
/Producer(PDFsharp 1.32.2608-g \(www.pdfsharp.net\) \(Original: Adobe PDF Library 11.0\))
/SourceModified(D:20130716151429)
/Subject(EPAR)
/Title(Glivec, INN: imatinib)
>>
endobj
3 0 obj
<<
/Subtype/XML
/Type/Metadata
/Length 5146
>>
stream
2013-07-23T17:09:43+01:00
2013-07-23T17:08:47+01:00
2013-07-23T17:09:43+01:00
Acrobat PDFMaker 11 for Word
uuid:07aff6b8-ff5a-46c0-ae01-48ca2e1787c2
uuid:006082d5-fbfd-428f-8c1c-c58dd75328ee
2
application/pdf
Glivec, INN: imatinib
EPAR
CHMP
Glivec
INN: imatinib
Adobe PDF Library 11.0
Glivec, INN: imatinib
D:20130716151429
Translation Centre
en_GB
CURRENT,1.0
H-406-Summary-en
16/07/2013 15:14:29
16/07/2013 15:14:29
Flaunoe Lise
Flaunoe Lise
emea_document
EMA/436309/2013
EPAR
/01. Evaluation of Medicine/H-C/G-I/Glivec-000406/05 Post Authorisation/EPAR/Rev 20 (II-80 awaiting CD)/Summary
EMA/436309/2013
Flaunoe Lise
16/07/2013 15:14:29
endstream
endobj
4 0 obj
<<
/Count 9
/First 7 0 R
/Last 8 0 R
/Type/Outlines
>>
endobj
5 0 obj
<<
/Count 3
/Kids[9 0 R 10 0 R 11 0 R]
/Type/Pages
>>
endobj
6 0 obj
<<
/K 12 0 R
/ParentTree 13 0 R
/ParentTreeNextKey 5
/RoleMap 14 0 R
/Type/StructTreeRoot
>>
endobj
7 0 obj
<<
/A 15 0 R
/Next 16 0 R
/Parent 4 0 R
/Title(What is Glivec?)
>>
endobj
8 0 obj
<<
/A 17 0 R
/Parent 4 0 R
/Prev 18 0 R
/Title(Other information about Glivec)
>>
endobj
9 0 obj
<<
/Contents[19 0 R 20 0 R 21 0 R 22 0 R 23 0 R 24 0 R 25 0 R 26 0 R 181 0 R]
/CropBox[0 0 595.32 841.92]
/Group 27 0 R
/MediaBox[0 0 595.32 841.92]
/Parent 5 0 R
/Resources
<<
/ColorSpace
<<
/CS0 28 0 R
/CS1 29 0 R
/CS2 30 0 R
/CS3 31 0 R
>>
/ExtGState
<<
/GS0 32 0 R
/GS1 182 0 R
>>
/Font
<<
/C2_0 33 0 R
/C2_1 34 0 R
/TT0 35 0 R
/TT1 36 0 R
/TT2 37 0 R
>>
/XObject
<<
/Im0 38 0 R
/Im1 39 0 R
>>
>>
/Rotate 0
/StructParents 0
/Tabs/S
/Type/Page
>>
endobj
10 0 obj
<<
/Contents[40 0 R 183 0 R]
/CropBox[0 0 595.32 841.92]
/MediaBox[0 0 595.32 841.92]
/Parent 5 0 R
/Resources
<<
/ColorSpace
<<
/CS0 29 0 R
/CS1 30 0 R
>>
/Font
<<
/C2_0 33 0 R
/C2_1 41 0 R
/TT0 37 0 R
/TT1 35 0 R
/TT2 36 0 R
>>
/ExtGState
<<
/GS0 182 0 R
>>
>>
/Rotate 0
/StructParents 1
/Tabs/S
/Type/Page
/Group
<<
/CS/DeviceRGB
/S/Transparency
/I false
/K false
>>
>>
endobj
11 0 obj
<<
/Annots 42 0 R
/Contents[43 0 R 184 0 R]
/CropBox[0 0 595.32 841.92]
/MediaBox[0 0 595.32 841.92]
/Parent 5 0 R
/Resources
<<
/ColorSpace
<<
/CS0 30 0 R
/CS1 29 0 R
>>
/Font
<<
/TT0 35 0 R
/TT1 36 0 R
>>
/ExtGState
<<
/GS0 182 0 R
>>
>>
/Rotate 0
/StructParents 2
/Tabs/S
/Type/Page
/Group
<<
/CS/DeviceRGB
/S/Transparency
/I false
/K false
>>
>>
endobj
12 0 obj
<<
/K[44 0 R 45 0 R 46 0 R 47 0 R 48 0 R 49 0 R 50 0 R 51 0 R 52 0 R 53 0 R 54 0 R 55 0 R 56 0 R 57 0 R 58 0 R 59 0 R 60 0 R 61 0 R 62 0 R 63 0 R 64 0 R 65 0 R 66 0 R 67 0 R 68 0 R 69 0 R 70 0 R 71 0 R 72 0 R 73 0 R 74 0 R 75 0 R 76 0 R 77 0 R]
/P 6 0 R
/S/Sect
>>
endobj
13 0 obj
<<
/Nums[0 78 0 R 1 79 0 R 2 80 0 R 3 81 0 R 4 81 0 R]
>>
endobj
14 0 obj
<<
/Annotation/Span
/Artifact/P
/Bibliography/BibEntry
/Body#20text#20#28Agency#29/P
/Chart/Figure
/Diagram/Figure
/Doc#20category#20heading#20#28Agency#29/P
/Doc#20subtitle#20#28Agency#29/P
/Doc#20title#20#28Agency#29/P
/DropCap/Figure
/Endnote/Note
/Footnote/Note
/InlineShape/Figure
/No-num#20heading#203#20#28Agency#29/H3
/Outline/Span
/Ref.#20#28Agency#29/P
/Strikeout/Span
/Subscript/Span
/Superscript/Span
/TextBox/Art
/Underline/Span
>>
endobj
15 0 obj
<<
/D[9 0 R/XYZ 60 435 0]
/S/GoTo
>>
endobj
16 0 obj
<<
/A 82 0 R
/Next 83 0 R
/Parent 4 0 R
/Prev 7 0 R
/Title(What is Glivec used for?)
>>
endobj
17 0 obj
<<
/D[11 0 R/XYZ 60 313 0]
/S/GoTo
>>
endobj
18 0 obj
<<
/A 84 0 R
/Next 8 0 R
/Parent 4 0 R
/Prev 85 0 R
/Title(Why has Glivec been approved?)
>>
endobj
19 0 obj
<<
/Filter/FlateDecode
/Length 812
>>
stream
x}Tn1W(F]# ($F@ЃqRR4_R7iF>>>Y5nqvprҌv~}~Ӧ[o[sz
SDR
B]Dˇf͇y3BӥEXzޝA*DtKp
UuW_avK wCE*ƨd dgcl=9Bsmf˪p>紫K:Яqk
0[UM!2tCMΚ $G
ݲbոL/Hs)Yb4eZ
){ep:I;-1Qn6xp%3[ 3B8T{BZ )d<ʱ0+3zx /=2ѱLӈbuzOG
r_P±ȫ[!eΈ28b|ⱧZU0M^?.~'dl
} (Tӽ'/5F>l0AU4>jMsԚQh;E&=]۬=)3JKW)!MGt[\#U9SFuT_*sR"R<|
endstream
endobj
20 0 obj
<<
/Filter/FlateDecode
/Length 743
>>
stream
x}UMO0ﯘ]&^HJ
T=@iJd?7{7Kc͛730͜|mŕeq^]hm&KG;gzK|[]~jԥ=Ϋ T4v&CH٢h'l\Io?q\&w{H^ѥqF3B+&H+}v p?p>g6> [CE_u=R
N20Kk[Z
w>Mr_%Xnn&scxKR(ы:YE